Finepoint Capital LP
- SEC CIK
- 0001608126
- Latest filing
- Aug 13, 2026
CERE holding history
Cerevel Therapeutics Holdings, Inc. in every 13F filed by Finepoint Capital LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CERE overviewAll 13F holders of CEREFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −563,345−100.0% | Sold out | Holders |
| Q3 2023 | 563,345 | $12.3M | 6.1% | +70,800+14.4% | Added | Holders |
| Q2 2023 | 492,545 | $15.7M | 5.4% | −46,900−8.7% | Reduced | Holders |
| Q1 2023 | 539,445 | $13.2M | 5.0% | +22,158+4.3% | Added | Holders |
| Q4 2022 | 517,287 | $16.3M | 5.3% | −19,614−3.7% | Reduced | Holders |
| Q3 2022 | 536,901 | $15.2M | 5.0% | +536,901 | New | Holders |